Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Conditions: Glioblastoma Multiforme; Glioblastoma; Glioma; Brain Tumor; Neoplasms; Neoplasms, Nerve Tissue Interventions: Device: NaviFUS System; Drug: Lumason; Drug: Bevacizumab Sponsors: NaviFUS Corporation; NaviFUS US LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials